Your cart is currently empty!
8 Results
5 Results
4 Results
Columbia Biosciences and AlphaThera partner to develop range of Site-Specific Fluorescent Protein Labeling Reagents
The partnership will provide the life science market with an innovative conjugation chemistry for antibody labeling.
Expansion of AlphaThera’s Distributor Network supports worldwide delivery of oYo-Link Antibody Labeling Technology
AlphaThera has announced the further expansion of its distributor network as interest in their oYo-Link Site Specific Antibody Labeling Technology continues to grow on an international scale.
oYo-Link® Products Now Available to Purchase through Quartzy
AlphaThera has teamed up with Quartzy to make their oYo-Link Antibody labeling products conveniently available to researchers for purchase.
Funakoshi Co., Ltd. Announced as AlphaThera’s Distribution Partner in Japan
AlphaThera has announced a distribution agreement with Funakoshi Co., Ltd. to deliver oYo-Link® Antibody labeling products to researchers in Japan.
5 Results
Columbia Biosciences and AlphaThera partner to develop range of Site-Specific Fluorescent Protein Labeling Reagents
The partnership will provide the life science market with an innovative conjugation chemistry for antibody labeling.
AlphaThera announces the launch of oYo-Capture™ Magnetic Beads
For the efficient removal of free oYo-Link® post conjugation AlphaThera has announced the launch of oYo-Capture™ Magnetic Beads, providing researchers with an efficient method of removing free oYo-Link® reagents post antibody conjugation to ensure low background in high sensitivity assays. AlphaThera is well known within the life science research community for their oYo-Link® antibody labeling […]
AlphaThera launches oYo-Link® Horseradish Peroxidase (HRP)
AlphaThera has announced the launch of oYo-Link® Horseradish Peroxidase (HRP), the latest addition to their range of site-specific antibody labeling reagents. The oYo-Link antibody-HRP labeling technology will enable the rapid production of highly uniform primary antibody conjugates in under two hours, and with only 30 seconds hands-on time.
AlphaThera Expand Their Range of oYo-Link Antibody-Drug Conjugate Reagents
AlphaThera have announced the addition of DM4 to their range of oYo-Link® Antibody-Drug Conjugation Reagents which also includes VcMMAE, VcMMAF and DM1.
AlphaThera Launches oYo-Link® Epitope Tag for Enhanced Multiplexing Capability
AlphaThera has announced the launch of oYo-Link® Epitope Tag, the latest addition to their range of site-specific antibody labeling reagents.
4 Results
AlphaThera Highlighted in Nature Methods Article: “How single-cell multi-omics builds relationships”
Dr. Andrew Tsourkas and Dr. Feifan Yu interview about oYo-Link Oligo technology and its potential within the field of multi-omic single-cell analysis.
AlphaThera & Penn Researchers’ Publication: Efficient native IgG labeling for ADC Production
AlphaThera members & Penn researchers worked to publish a high-impact publication in Bioconjugate Chemistry titled “Efficient Labeling of Native Human IgG by Proximity-Based Sortase-Mediated Isopeptide Ligation”.
Publication Feature: “Targeting cartilage EGFR pathway for osteoarthritis treatment” Science Translational Medicine
Read how a research team used AlphaThera’s site-specific bioconjugation technique to seed nanoparticles with a TGFa payload.
AlphaThera in the News: Atlas of Science
A layman’s summary of AlphaThera’s LASIC site-specific Antibody labeling technology was published by the Atlas of Science.